Simon Lindner

Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases

Xianyuan Xiang, Karin Wind, Thomas Wiedemann et al. · Science Translational Medicine · 2021 · 245 citations

Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study

Matthias Brendel, Federico Probst, Anna Jaworska et al. · Journal of Nuclear Medicine · 2016 · 150 citations · Full text

TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma

Nathalie L. Albert, Marcus Unterrainer, Daniel F. Fleischmann et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 126 citations

Positron Emission Tomography, Neuro-oncology, Novel Ligand 18F-ge-180 +13

Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors

Harun Ilhan, Simon Lindner, Andrei Todica et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 117 citations

Positron Emission Tomography, First Clinical Results, Oncology +12

TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study

Marcus Unterrainer, Daniel F. Fleischmann, Franziska Vettermann et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 76 citations

Positron Emission Tomography, Tumoral Pathology, Glioma +14